Tidemandsen Jens

8PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Gene and molecular therapySensory systemsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 20, 2026
AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

|Jul 11, 2026
Improved VO2max following anti-IL-5 therapy in severe eosinophilic CRSwNP: exploratory associations with cardiac inflammatory biomarkers.

|Apr 13, 2026
Functional Endoscopic Sinus Surgery in Adults With CRSwNP Treated With Mepolizumab: Airway Physiology Outcomes From a Randomised Controlled Trial.

Jens Tidemandsen, Anne Sophie Homøe, Peter G Gibson

|Apr 03, 2026
Response to the Letter to the Editor by Pirola and Hopkins Regarding "The Global Airways in Practice: Long-Term Effects of Mepolizumab with or without FESS on Type 2 Inflammation in Patients with CRSwNP".

Jens Tidemandsen, Vibeke Backer, Howraman Meteran

|Mar 28, 2026
Psychophysical Olfactory Outcomes After Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis.

Christian K Pedersen, Vibeke Backer, Jens Even Tidemandsen

|Jan 09, 2026
Mepolizumab treatment is associated with physical activity and cardiorespiratory fitness irrespective of endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps: a randomised controlled trial.

Tidemandsen Jens, Hostrup Morten, Homøe Anne-Sophie

Pageof 2

Frequent Collaborators

4 joint publications

Marie Høxbro

4 joint publications

Anne-Sophie Homøe

3 joint publications

Vibeke Backer

3 joint publications

Simon Høj